Mandate

Vinge advises Capio in connection with the acquisition of the Nova clinics

February 26, 2018 M&A

Vinge has advised Capio, which is listed on Nasdaq Stockholm, in connection with the acquisition of the shares in the Nova clinics.

The Nova clinics primarily conduct healthcare operations at eight clinics in the southeast of Skåne and have certain operations within occupational health service and dental service. In 2017, the Nova clinics had a turnover of approximately MSEK 245 and had approximately 45 000 listed patients. The purchase price mechanism, which is based on Enterprise Value, amounts to MSEK 88. The acquisition is conditional upon the Swedish Competition Authority’s and Region Skåne’s approval.

Vinge’s team consisted of Anders Strid, Frida Bäckegren (project manager), Gabriella Fossum (LOU), Rebecka Maltenius (commercial property law), Lina André (employment law), Camilla Andersson (company registration assistant) as well as Pär Remenlid and Nils Alvång (both competition law).

Related

Vinge advises HealthCap in conjunction with an investment in Neobiomics

HealthCap is investing in Neobiomics AB, which develops products in the neonatal field. Neobiomics’ flagship product, Proprems, is a probiotic dietary supplement developed for preterm infants.
May 22, 2026

Vinge advises Sveafastigheter in its merger with KlaraBo

Vinge advises Sveafastigheter AB (publ) in its merger with KlaraBo Sverige AB.
May 22, 2026

Vinge advises Lagercrantz Group in conjunction with the acquisition of Stalon

Lagercrantz Group Aktiebolag has acquired 88 per cent of the shares in Stalon AB, a Swedish manufacturer of silencers for hunting firearms. The company is based in Stalon, which is located outside Vilhelmina, where the company conducts development and production in its own facilities.
May 21, 2026